Genomic & Biopharma News

Good news for patients with NFI-related low grade gliomas
A paper published in the academic journal Neuro-Oncology by NF experts has demonstrated an increased understanding of low grade gliomas (LGG) occurring in children and adults with NF1.
News Medical Life Sciences, 2020-04-01 21:47:09

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests.
ORB Company News, 2016-12-28 18:58:47

Researchers identify risk gene for Alzheimer's development
Researchers from the University of British Columbia and the Central South University in China have for the first time identified a gene that increases the risk of Alzheimer's disease.
News Medical Life Sciences, 2020-04-01 20:53:31

Some Coronavirus Researchers are Running Low on Masks
A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.
The Scientist, 2020-04-01 20:48:51

A non-invasive method to predict intracranial pressure
The only way to accurately measure pressure inside the skull is to insert a catheter or sensor inside.
News Medical Life Sciences, 2020-04-01 20:47:40

Inherited gene mutation can predispose children to SHH medulloblastoma
Investigators at St. Jude Children's Research Hospital, the European Molecular Biology Laboratory, and the German Cancer Research Center have identified ELP1 as a novel predisposition gene in the SHH subgroup of pediatric medulloblastoma.
News Medical Life Sciences, 2020-04-01 20:43:00

HIV Researcher Gita Ramjee Dies of Complications Tied to COVID-19
The South African scientist fought for women’s access to healthcare in disadvantaged communities.
The Scientist, 2020-04-01 20:31:28

iTeos reels in $125M to shepherd I-O prospects through the clinic
Nearly two years after raising $75 million to move two immuno-oncology meds into the clinic, iTeos Therapeutics has come back for more. Now, it’s picking up $125 million in a series B2 round that will push its lead assets through phase 1/2 trials.
Fierce Biotech, 2020-04-01 18:36:35

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
ORB Company News, 2016-12-28 18:58:47

With Bristol Myers' latest CAR-T filing, Celgene investors inch closer to payout
Bristol Myers Squibb and bluebird bio filed their BCMA-targeting CAR-T therapy for FDA approval, teeing it up for a potential green light in 2020—and laying the groundwork for a potential payout to Celgene investors. The treatment, known as bb2121 or idecabtagene vicleucel (ide-cel), is one of three programs upon which BMS’ acquisition of Celgene hinged.
Fierce Biotech, 2020-04-01 16:36:13

Zantac, generics ordered off the market after FDA finds they're a ticking time bomb
Nearly four decades after it was approved, the FDA has ordered that heartburn drug Zantac and its generics be removed from the market, saying they have been exposing consumers to the risk of cancer. 
Fierce Pharma, 2020-04-01 15:52:01